Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children's Oncology Group phase 1 consortium study (ADVL1212).
Emily G GreengardYael P MosseXiaowei LiuCharles G MinardJoel M ReidStephan VossKeith WilnerElizabeth FoxFrank BalisSusan M BlaneyPeter C AdamsonBrenda J WeigelPublished in: Cancer chemotherapy and pharmacology (2020)
The trial is registered as NCT01606878 at Clinicaltrials.gov.